|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.000 USD | -.--% |
|
-.--% | - |
| 14-03-13 | Pegasus Pharmaceuticals Develops Natural All-Purpose Cleaner/Degreaser | CI |
| 14-01-28 | Pegasus Pharmaceuticals Develops and Completes Testing of MoldGuardian a New Anti-Fungi Product | CI |
| 21-12-21 | Pegasus Pharmaceuticals : Quarterly Report | PU |
| Current year | 5 | 5 | |
| 1 year | 5 | 5 | |
| 3 years | 1.02 | 23 | |
| 5 years | 1.02 | 89.7 | |
| 10 years | 1 | 148.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Samuel Eisenberg
CEO | Chief Executive Officer | - | 2021-10-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Samuel Eisenberg
BRD | Director/Board Member | - | 2021-10-11 |
Employees
-
Sector
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-09 | US$0.000000 | - | 50 |
- Stock Market
- Stocks
- DVTC Stock
Select your edition
All financial news and data tailored to specific country editions
















